A citation-based method for searching scientific literature

Hironori Uruga, Mari Mino-Kenudson. Virchows Arch 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Venous Thromboembolism in Patients Diagnosed With Lung Cancer.
E Salla, Evangelos P Dimakakos, S Tsagkouli, I Giozos, A Charpidou, E Kainis, K N Syrigos. Angiology 2016
16
50

Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer.
Katelyn M Atkins, Bhupendra Rawal, Tafadzwa L Chaunzwa, Nayan Lamba, Danielle S Bitterman, Christopher L Williams, David E Kozono, Elizabeth H Baldini, Aileen B Chen, Paul L Nguyen,[...]. J Am Coll Cardiol 2019
66
50

Identification of the molecular basis of doxorubicin-induced cardiotoxicity.
Sui Zhang, Xiaobing Liu, Tasneem Bawa-Khalfe, Long-Sheng Lu, Yi Lisa Lyu, Leroy F Liu, Edward T H Yeh. Nat Med 2012
909
50

Lung cancer as a cardiotoxic state: a review.
David Pérez-Callejo, María Torrente, María Auxiliadora Brenes, Beatriz Núñez, Mariano Provencio. Med Oncol 2017
4
50

Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.
Alexander Drilon, Theodore W Laetsch, Shivaani Kummar, Steven G DuBois, Ulrik N Lassen, George D Demetri, Michael Nathenson, Robert C Doebele, Anna F Farago, Alberto S Pappo,[...]. N Engl J Med 2018
50


Small-cell lung cancer.
Jan P van Meerbeeck, Dean A Fennell, Dirk K M De Ruysscher. Lancet 2011
578
50

Non-small-cell lung cancer.
Peter Goldstraw, David Ball, James R Jett, Thierry Le Chevalier, Eric Lim, Andrew G Nicholson, Frances A Shepherd. Lancet 2011
482
50

Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis.
Julia Kravchenko, Mark Berry, Konstantin Arbeev, H Kim Lyerly, Anatoly Yashin, Igor Akushevich. Lung Cancer 2015
46
50

Congestive Heart Failure During Osimertinib Treatment for Epidermal Growth Factor Receptor (EGFR)-mutant Non-small Cell Lung Cancer (NSCLC).
Hiromi Watanabe, Eiki Ichihara, Hirohisa Kano, Kiichiro Ninomiya, Mitsune Tanimoto, Katsuyuki Kiura. Intern Med 2017
16
50

Chemotherapy of lung cancer.
D C Ihde. N Engl J Med 1992
421
50

Cardiovascular Complications of Systemic Therapy in Non-Small-Cell Lung Cancer.
Magdalena Zaborowska-Szmit, Maciej Krzakowski, Dariusz M Kowalski, Sebastian Szmit. J Clin Med 2020
8
50

Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
Carrie G Lenneman, Douglas B Sawyer. Circ Res 2016
157
50

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial.
Kazuhiko Nakagawa, Edward B Garon, Takashi Seto, Makoto Nishio, Santiago Ponce Aix, Luis Paz-Ares, Chao-Hua Chiu, Keunchil Park, Silvia Novello, Ernest Nadal,[...]. Lancet Oncol 2019
166
50

Gefitinib affects functions of platelets and blood vessels via changes in prostanoids balance.
Shigenori Kanazawa, Kazuyuki Yamaguchi, Yoshimi Kinoshita, Mikiko Muramatsu, Yutaka Komiyama, Shosaku Nomura. Clin Appl Thromb Hemost 2005
11
50

Entrectinib for the treatment of metastatic NSCLC: safety and efficacy.
Andrea Sartore-Bianchi, Elio Gregory Pizzutilo, Giovanna Marrapese, Federica Tosi, Giulio Cerea, Salvatore Siena. Expert Rev Anticancer Ther 2020
9
50

What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment.
Enrico Bronte, Giuseppe Bronte, Giuseppina Novo, Fabrizio Bronte, Maria Grazia Bavetta, Giuseppe Lo Re, Giuseppe Brancatelli, Viviana Bazan, Clara Natoli, Salvatore Novo,[...]. Oncotarget 2015
27
50

Crizotinib-induced cardiotoxicity: the importance of a proactive monitoring and management.
Alfredo Tartarone, Giuseppina Gallucci, Chiara Lazzari, Rosa Lerose, Lucia Lombardi, Michele Aieta. Future Oncol 2015
19
50

Safety and efficacy of first-line dacomitinib in Japanese patients with advanced non-small cell lung cancer.
Makoto Nishio, Terufumi Kato, Seiji Niho, Noboru Yamamoto, Toshiaki Takahashi, Naoyuki Nogami, Hiroyasu Kaneda, Yuka Fujita, Keith Wilner, Mizuki Yoshida,[...]. Cancer Sci 2020
7
50

Biology of small-cell lung cancer.
D N Carney. Lancet 1992
46
50

Risk of ischemic heart disease in women after radiotherapy for breast cancer.
Sarah C Darby, Marianne Ewertz, Paul McGale, Anna M Bennet, Ulla Blom-Goldman, Dorthe Brønnum, Candace Correa, David Cutter, Giovanna Gagliardi, Bruna Gigante,[...]. N Engl J Med 2013
50

Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis.
Javid J Moslehi, Joe-Elie Salem, Jeffrey A Sosman, Bénédicte Lebrun-Vignes, Douglas B Johnson. Lancet 2018
340
50

Cardiovascular Adverse Events Associated With BRAF and MEK Inhibitors: A Systematic Review and Meta-analysis.
Raluca I Mincu, Amir A Mahabadi, Lars Michel, Simone M Mrotzek, Dirk Schadendorf, Tienush Rassaf, Matthias Totzeck. JAMA Netw Open 2019
27
50

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
50

Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial.
Martin Reck, Rolf Kaiser, Anders Mellemgaard, Jean-Yves Douillard, Sergey Orlov, Maciej Krzakowski, Joachim von Pawel, Maya Gottfried, Igor Bondarenko, Meilin Liao,[...]. Lancet Oncol 2014
551
50

Lung cancer.
Roy S Herbst, John V Heymach, Scott M Lippman. N Engl J Med 2008
50


Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance.
Filipe Martins, Latifyan Sofiya, Gerasimos P Sykiotis, Faiza Lamine, Michel Maillard, Montserrat Fraga, Keyvan Shabafrouz, Camillo Ribi, Anne Cairoli, Yan Guex-Crosier,[...]. Nat Rev Clin Oncol 2019
413
50

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.
J Guillermo Paez, Pasi A Jänne, Jeffrey C Lee, Sean Tracy, Heidi Greulich, Stacey Gabriel, Paula Herman, Frederic J Kaye, Neal Lindeman, Titus J Boggon,[...]. Science 2004
50


Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.
Eunice L Kwak, Yung-Jue Bang, D Ross Camidge, Alice T Shaw, Benjamin Solomon, Robert G Maki, Sai-Hong I Ou, Bruce J Dezube, Pasi A Jänne, Daniel B Costa,[...]. N Engl J Med 2010
50

BRAFV600E and BRAF-inactivating mutations in NSCLC.
Rafael Rosell, Niki Karachaliou. Lancet Oncol 2017
4
50

Small-cell lung cancer.
David M Jackman, Bruce E Johnson. Lancet 2005
373
50

Cardio-Oncology Services: rationale, organization, and implementation.
Patrizio Lancellotti, Thomas M Suter, Teresa López-Fernández, Maurizio Galderisi, Alexander R Lyon, Peter Van der Meer, Alain Cohen Solal, Jose-Luis Zamorano, Guy Jerusalem, Marie Moonen,[...]. Eur Heart J 2019
98
50

Lung cancer: current therapies and new targeted treatments.
Fred R Hirsch, Giorgio V Scagliotti, James L Mulshine, Regina Kwon, Walter J Curran, Yi-Long Wu, Luis Paz-Ares. Lancet 2017
50

Cardiotoxicity of Immune Checkpoint Inhibitors.
Lili Zhang, Maeve Jones-O'Connor, Magid Awadalla, Daniel A Zlotoff, Paaladinesh Thavendiranathan, John D Groarke, Alexandra-Chloe Villani, Alexander R Lyon, Tomas G Neilan. Curr Treat Options Cardiovasc Med 2019
24
50

Crizotinib in ROS1-rearranged non-small-cell lung cancer.
Alice T Shaw, Sai-Hong I Ou, Yung-Jue Bang, D Ross Camidge, Benjamin J Solomon, Ravi Salgia, Gregory J Riely, Marileila Varella-Garcia, Geoffrey I Shapiro, Daniel B Costa,[...]. N Engl J Med 2014
50

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.
Alan Sandler, Robert Gray, Michael C Perry, Julie Brahmer, Joan H Schiller, Afshin Dowlati, Rogerio Lilenbaum, David H Johnson. N Engl J Med 2006
50

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.
Leora Horn, Aaron S Mansfield, Aleksandra Szczęsna, Libor Havel, Maciej Krzakowski, Maximilian J Hochmair, Florian Huemer, György Losonczy, Melissa L Johnson, Makoto Nishio,[...]. N Engl J Med 2018
50

Target binding properties and cellular activity of afatinib (BIBW 2992), an irreversible ErbB family blocker.
Flavio Solca, Goeran Dahl, Andreas Zoephel, Gerd Bader, Michael Sanderson, Christian Klein, Oliver Kraemer, Frank Himmelsbach, Eric Haaksma, Guenther R Adolf. J Pharmacol Exp Ther 2012
541
50

Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations.
G Curigliano, D Lenihan, M Fradley, S Ganatra, A Barac, A Blaes, J Herrmann, C Porter, A R Lyon, P Lancellotti,[...]. Ann Oncol 2020
172
50

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
Paul M Ridker, Brendan M Everett, Tom Thuren, Jean G MacFadyen, William H Chang, Christie Ballantyne, Francisco Fonseca, Jose Nicolau, Wolfgang Koenig, Stefan D Anker,[...]. N Engl J Med 2017
50

Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.
Tony S Mok, Yi-Long Wu, Myung-Ju Ahn, Marina C Garassino, Hye R Kim, Suresh S Ramalingam, Frances A Shepherd, Yong He, Hiroaki Akamatsu, Willemijn S M E Theelen,[...]. N Engl J Med 2017
50

Managing cardiotoxicity of chemotherapy.
Alessandro Colombo, Carlo A Meroni, Carlo M Cipolla, Daniela Cardinale. Curr Treat Options Cardiovasc Med 2013
27
50


Cardiovascular toxicities associated with immune checkpoint inhibitors.
Jiun-Ruey Hu, Roberta Florido, Evan J Lipson, Jarushka Naidoo, Reza Ardehali, Carlo G Tocchetti, Alexander R Lyon, Robert F Padera, Douglas B Johnson, Javid Moslehi. Cardiovasc Res 2019
130
50

Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.
David Ball, G Tao Mai, Shalini Vinod, Scott Babington, Jeremy Ruben, Tomas Kron, Brent Chesson, Alan Herschtal, Marijana Vanevski, Angela Rezo,[...]. Lancet Oncol 2019
172
50

Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines.
G Curigliano, D Cardinale, T Suter, G Plataniotis, E de Azambuja, M T Sandri, C Criscitiello, A Goldhirsch, C Cipolla, F Roila. Ann Oncol 2012
453
50

The biology and management of non-small cell lung cancer.
Roy S Herbst, Daniel Morgensztern, Chris Boshoff. Nature 2018
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.